1.Risk of Subsequent Events in Patients With Minor Ischemic Stroke or HighRisk Transient Ischemic Attack
Keon-Joo LEE ; Dong Woo SHIN ; Hong-Kyun PARK ; Beom Joon KIM ; Jong-Moo PARK ; Kyusik KANG ; Tai Hwan PARK ; Kyung Bok LEE ; Keun-Sik HONG ; Yong-Jin CHO ; Dong-Eog KIM ; Wi-Sun RYU ; Byung-Chul LEE ; Kyung-Ho YU ; Mi-Sun OH ; Soo Joo LEE ; Jae Guk KIM ; Jun LEE ; Jae-Kwan CHA ; Dae-Hyun KIM ; Joon-Tae KIM ; Kang-Ho CHOI ; Jay Chol CHOI ; Eva LESÉN ; Jonatan HEDBERG ; Amarjeet TANK ; Edmond G. FITA ; Ji Eun SONG ; Ji Sung LEE ; Juneyoung LEE ; Hee-Joon BAE ;
Journal of Korean Medical Science 2022;37(33):e254-
This study aimed to present the prognosis after minor acute ischemic stroke (AIS) or transient ischemic attack (TIA), using a definition of subsequent stroke in accordance with recent clinical trials. In total, 9,506 patients with minor AIS (National Institutes of Health Stroke Scale ≤ 5) or high-risk TIA (acute lesions or ≥ 50% cerebral artery steno-occlusion) admitted between November 2010 and October 2013 were included. The primary outcome was the composite of stroke (progression of initial event or a subsequent event) and all-cause mortality. The cumulative incidence of stroke or death was 11.2% at 1 month, 13.3% at 3 months and 16.7% at 1 year. Incidence rate of stroke or death in the first month was 12.5 per 100 person-months: highest in patients with large artery atherosclerosis (17.0). The risk of subsequent events shortly after a minor AIS or high-risk TIA was substantial, particularly in patients with large artery atherosclerosis.
2.Erratum: Structural and Functional Features on Quantitative Chest Computed Tomography in the Korean Asian versus the White American Healthy Non-Smokers
Hyun Bin CHO ; Kum Ju CHAE ; Gong Yong JIN ; Jiwoong CHOI ; Ching Long LIN ; Eric A HOFFMAN ; Sally E WENZEL ; Mario CASTRO ; Sean B FAIN ; Nizar N JARJOUR ; Mark L SCHIEBLER ; R Graham BARR ; Nadia HANSEL ; Christopher B COOPER ; Eric C KLEERUP ; MeiLan K HAN ; Prescott G WOODRUFF ; Richard E KANNER ; Eugene R BLEECKER ; Stephen P PETERS ; Wendy C MOORE ; Chang Hyun LEE ; Sanghun CHOI ;
Korean Journal of Radiology 2020;21(1):117-117
3.Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility
Ashok AGARWAL ; Neel PAREKH ; Manesh Kumar PANNER SELVAM ; Ralf HENKEL ; Rupin SHAH ; Sheryl T HOMA ; Ranjith RAMASAMY ; Edmund KO ; Kelton TREMELLEN ; Sandro ESTEVES ; Ahmad MAJZOUB ; Juan G ALVAREZ ; David K GARDNER ; Channa N JAYASENA ; Jonathan W RAMSAY ; Chak Lam CHO ; Ramadan SALEH ; Denny SAKKAS ; James M HOTALING ; Scott D LUNDY ; Sarah VIJ ; Joel MARMAR ; Jaime GOSALVEZ ; Edmund SABANEGH ; Hyun Jun PARK ; Armand ZINI ; Parviz KAVOUSSI ; Sava MICIC ; Ryan SMITH ; Gian Maria BUSETTO ; Mustafa Emre BAKIRCIOĞLU ; Gerhard HAIDL ; Giancarlo BALERCIA ; Nicolás Garrido PUCHALT ; Moncef BEN-KHALIFA ; Nicholas TADROS ; Jackson KIRKMAN-BROWNE ; Sergey MOSKOVTSEV ; Xuefeng HUANG ; Edson BORGES ; Daniel FRANKEN ; Natan BAR-CHAMA ; Yoshiharu MORIMOTO ; Kazuhisa TOMITA ; Vasan Satya SRINI ; Willem OMBELET ; Elisabetta BALDI ; Monica MURATORI ; Yasushi YUMURA ; Sandro LA VIGNERA ; Raghavender KOSGI ; Marlon P MARTINEZ ; Donald P EVENSON ; Daniel Suslik ZYLBERSZTEJN ; Matheus ROQUE ; Marcello COCUZZA ; Marcelo VIEIRA ; Assaf BEN-MEIR ; Raoul ORVIETO ; Eliahu LEVITAS ; Amir WISER ; Mohamed ARAFA ; Vineet MALHOTRA ; Sijo Joseph PAREKATTIL ; Haitham ELBARDISI ; Luiz CARVALHO ; Rima DADA ; Christophe SIFER ; Pankaj TALWAR ; Ahmet GUDELOGLU ; Ahmed M A MAHMOUD ; Khaled TERRAS ; Chadi YAZBECK ; Bojanic NEBOJSA ; Damayanthi DURAIRAJANAYAGAM ; Ajina MOUNIR ; Linda G KAHN ; Saradha BASKARAN ; Rishma Dhillon PAI ; Donatella PAOLI ; Kristian LEISEGANG ; Mohamed Reza MOEIN ; Sonia MALIK ; Onder YAMAN ; Luna SAMANTA ; Fouad BAYANE ; Sunil K JINDAL ; Muammer KENDIRCI ; Baris ALTAY ; Dragoljub PEROVIC ; Avi HARLEV
The World Journal of Men's Health 2019;37(3):296-312
Despite advances in the field of male reproductive health, idiopathic male infertility, in which a man has altered semen characteristics without an identifiable cause and there is no female factor infertility, remains a challenging condition to diagnose and manage. Increasing evidence suggests that oxidative stress (OS) plays an independent role in the etiology of male infertility, with 30% to 80% of infertile men having elevated seminal reactive oxygen species levels. OS can negatively affect fertility via a number of pathways, including interference with capacitation and possible damage to sperm membrane and DNA, which may impair the sperm's potential to fertilize an egg and develop into a healthy embryo. Adequate evaluation of male reproductive potential should therefore include an assessment of sperm OS. We propose the term Male Oxidative Stress Infertility, or MOSI, as a novel descriptor for infertile men with abnormal semen characteristics and OS, including many patients who were previously classified as having idiopathic male infertility. Oxidation-reduction potential (ORP) can be a useful clinical biomarker for the classification of MOSI, as it takes into account the levels of both oxidants and reductants (antioxidants). Current treatment protocols for OS, including the use of antioxidants, are not evidence-based and have the potential for complications and increased healthcare-related expenditures. Utilizing an easy, reproducible, and cost-effective test to measure ORP may provide a more targeted, reliable approach for administering antioxidant therapy while minimizing the risk of antioxidant overdose. With the increasing awareness and understanding of MOSI as a distinct male infertility diagnosis, future research endeavors can facilitate the development of evidence-based treatments that target its underlying cause.
Antioxidants
;
Classification
;
Clinical Protocols
;
Diagnosis
;
DNA
;
Embryonic Structures
;
Female
;
Fertility
;
Health Expenditures
;
Humans
;
Infertility
;
Infertility, Male
;
Male
;
Membranes
;
Ovum
;
Oxidants
;
Oxidation-Reduction
;
Oxidative Stress
;
Reactive Oxygen Species
;
Reducing Agents
;
Reproductive Health
;
Semen
;
Spermatozoa
;
Subject Headings
4.Structural and Functional Features on Quantitative Chest Computed Tomography in the Korean Asian versus the White American Healthy Non-Smokers
Hyun Bin CHO ; Kum Ju CHAE ; Gong Yong JIN ; Jiwoong CHOI ; Ching Long LIN ; Eric A HOFFMAN ; Sally E WENZEL ; Mario CASTRO ; Sean B FAIN ; Nizar N JARJOUR ; Mark L SCHIEBLER ; R Graham BARR ; Nadia HANSEL ; Christopher B COOPER ; Eric C KLEERUP ; MeiLan K HAN ; Prescott G WOODRUFF ; Richard E KANNER ; Eugene R BLEECKER ; Stephen P PETERS ; Wendy C MOORE ; Chang Hyun LEE ; Sanghun CHOI ;
Korean Journal of Radiology 2019;20(7):1236-1245
OBJECTIVE: Considering the different prevalence rates of diseases such as asthma and chronic obstructive pulmonary disease in Asians relative to other races, Koreans may have unique airway structure and lung function. This study aimed to investigate unique features of airway structure and lung function based on quantitative computed tomography (QCT)-imaging metrics in the Korean Asian population (Koreans) as compared with the White American population (Whites). MATERIALS AND METHODS: QCT data of healthy non-smokers (223 Koreans vs. 70 Whites) were collected, including QCT structural variables of wall thickness (WT) and hydraulic diameter (Dh) and functional variables of air volume, total air volume change in the lung (ΔVair), percent emphysema-like lung (Emph%), and percent functional small airway disease-like lung (fSAD%). Mann-Whitney U tests were performed to compare the two groups. RESULTS: As compared with Whites, Koreans had smaller volume at inspiration, ΔVair between inspiration and expiration (p < 0.001), and Emph% at inspiration (p < 0.001). Especially, Korean females had a decrease of ΔVair in the lower lobes (p < 0.001), associated with fSAD% at the lower lobes (p < 0.05). In addition, Koreans had smaller Dh and WT of the trachea (both, p < 0.05), correlated with the forced expiratory volume in 1 second (R = 0.49, 0.39; all p < 0.001) and forced vital capacity (R = 0.55, 0.45; all p < 0.001). CONCLUSION: Koreans had unique features of airway structure and lung function as compared with Whites, and the difference was clearer in female individuals. Discriminating structural and functional features between Koreans and Whites enables exploration of inter-racial differences of pulmonary disease in terms of severity, distribution, and phenotype.
Asian Continental Ancestry Group
;
Asthma
;
Continental Population Groups
;
Female
;
Forced Expiratory Volume
;
Humans
;
Lung
;
Lung Diseases
;
Phenotype
;
Prevalence
;
Pulmonary Disease, Chronic Obstructive
;
Thorax
;
Trachea
;
Vital Capacity
5.Acer okamotoanum Inhibit the Hydrogen Peroxide-Induced Oxidative Stress in C6 Glial Cells
Soo Yeon CHOI ; Ji Hyun KIM ; Norman G QUILANTANG ; Sanghyun LEE ; Eun Ju CHO
Natural Product Sciences 2018;24(3):148-154
Chronic oxidative stress due to the accumulation of reactive oxygen species (ROS) in neuronal cells ultimately leads to neurodegenerative diseases. The use of natural therapies for the prevention of ROS-induced cell damage and for the treatment of neurodegenerative disorders has shown promising results. In this study, we evaluated the neuroprotective effects of the ethyl acetate (EtOAc) fraction of A. Okamotoanum against the hydrogen peroxide (H₂O₂)-induced oxidative stress in C6 glial cells. Results show that cell viability was decreased in cells incubated with H₂O₂, whereas the addition of EtOAc fraction treatments in such cells significantly increased viability. The EtOAc fraction showed the highest inhibitory activity against ROS production and it also decreased the expressions of inflammatory proteins including cyclooxygenase-2, inducible nitric oxide synthase and interleukin-1β. Furthermore, the EtOAc fraction inhibited apoptosis by regulating the protein expressions cleaved caspase
Acer
;
Apoptosis
;
Cell Survival
;
Cyclooxygenase 2
;
Hydrogen Peroxide
;
Hydrogen
;
Inflammation
;
Neurodegenerative Diseases
;
Neuroglia
;
Neurons
;
Neuroprotective Agents
;
Nitric Oxide Synthase Type II
;
Oxidative Stress
;
Poly(ADP-ribose) Polymerases
;
Reactive Oxygen Species
6.Quantitative Determination of Bakkenolide D in Petasites japonicus and Farfugium japonicum by HPLC/UV.
Norman G QUILANTANG ; Ki Ho LEE ; Dong Gu LEE ; Ju Sung LEE ; EunJu CHO ; Hyun Young KIM ; Sanghyun LEE
Natural Product Sciences 2017;23(4):270-273
A quantitative analysis of bakkenolide D in the different parts of Petasites japonicus and Farfugium japonicum was performed by HPLC. A gradient HPLC elution system with a mobile phase consisting of water:acetonitrile solution (20:80 to 0:100 for 45 min) was followed and an INNO C₁₈ column was used for the chromatographic separation. The injection volume, flow rate, and UV detection were 10 µL, 1 mL/min, and 290 nm, respectively. Results show that both species showed the highest amount of bakkenolide D in the roots being 107.203 and 166.103 mg/g for P. japonicas and F. japonicum, respectively. Content analysis on the different parts of both plants displayed remarkably lower values which ranged from 0.403 – 4.419 and 7.252 – 32.614 mg/g for P. japonicas and F. japonicum, respectively. The results show that the roots of both plants are rich in bakkenolide D showing a promising use in the development of nutraceuticals and industrial application of the compound.
Chromatography, High Pressure Liquid
;
Dietary Supplements
;
Petasites*
7.Clinical Practice Guidelines for Gastric Cancer in Korea: An Evidence-Based Approach.
Jun Haeng LEE ; Jae G KIM ; Hye Kyung JUNG ; Jung Hoon KIM ; Woo Kyoung JEONG ; Tae Joo JEON ; Joon Mee KIM ; Young Il KIM ; Keun Won RYU ; Seong Ho KONG ; Hyoung Il KIM ; Hwoon Yong JUNG ; Yong Sik KIM ; Dae Young ZANG ; Jae Yong CHO ; Joon Oh PARK ; Do Hoon LIM ; Eun Sun JUNG ; Hyeong Sik AHN ; Hyun Jung KIM
Journal of Gastric Cancer 2014;14(2):87-104
Although gastric cancer is quite common in Korea, the treatment outcome is relatively favorable compared to those in western countries. However, there are currently no Korean multidisciplinary guidelines for gastric cancer. Experts from related societies developed guidelines de novo to meet Korean circumstances and requirements, including 23 recommendation statements for diagnosis (n=9) and treatment (n=14) based on relevant key questions. The quality of the evidence was rated according to the GRADE evidence evaluation framework: the evidence levels were based on a systematic review of the literature, and the recommendation grades were classified as either strong or weak. The applicability of the guidelines was considered to meet patients' view and preferences in the context of Korea. The topics of the guidelines cover diagnostic modalities (endoscopy, endoscopic ultrasound, and radiologic diagnosis), treatment modalities (surgery, therapeutic endoscopy, chemotherapy, and radiotherapy), and pathologic evaluation. An external review of the guidelines was conducted during the finalization phase.
Diagnosis
;
Drug Therapy
;
Endoscopy
;
Korea
;
Stomach Neoplasms*
;
Treatment Outcome
;
Ultrasonography
8.Synopsis on Clinical Practice Guideline of Gastric Cancer in Korea: An Evidence-Based Approach.
Jun Haeng LEE ; Jae G KIM ; Hye Kyung JUNG ; Jung Hoon KIM ; Woo Kyoung JEONG ; Tae Joo JEON ; Joon Mee KIM ; Young Il KIM ; Keun Won RYU ; Seong Ho KONG ; Hyoung Il KIM ; Hwoon Yong JUNG ; Yong Sik KIM ; Dae Young ZANG ; Jae Yong CHO ; Joon Oh PARK ; Do Hoon LIM ; Eun Sun JUNG ; Hyeong Sik AHN ; Hyun Jung KIM
The Korean Journal of Gastroenterology 2014;63(2):66-81
Although, gastric cancer is quite common in Korea, the treatment outcome is relatively favorable compared to that of Western countries. However, there is no Korean multidisciplinary guideline for gastric cancer and thus, a guideline adequate for domestic circumstances is required. Experts from related societies developed 22 recommendation statements for the diagnosis (n=9) and treatment (n=13) based on relevant key questions. Evidence levels based on systematic review of literatures were classified as five levels from A to E, and recommendation grades were classified as either strong or weak. The topics of this guideline cover diagnostic modalities (endoscopy, endoscopic ultrasound, radiologic diagnosis), treatment modalities (surgery, therapeutic endoscopy, chemotherapy, radiotherapy) and pathologic evaluation. External review of the guideline was conducted at the finalization phase.
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
;
Chemoradiotherapy, Adjuvant
;
Endoscopy, Gastrointestinal
;
Endosonography
;
Evidence-Based Medicine
;
Follow-Up Studies
;
Gastrectomy
;
Humans
;
Magnetic Resonance Imaging
;
Positron-Emission Tomography
;
Republic of Korea
;
Stomach Neoplasms/*diagnosis/pathology/therapy
;
Tomography, X-Ray Computed
9.Noonan Syndrome Confirmed to KRAS Gene Mutation: A Case of KRAS Gene Mutation.
Sung Woo KIM ; So Eun PARK ; In Hyuk JEONG ; Jeong Won YOON ; Cho Ae LEE ; Ji hyun JEON
Journal of the Korean Society of Neonatology 2011;18(2):374-378
Noonan syndrome is an autosomal dominant disorder characterized by typical facial features, congenital heart disease, and short stature. Diagnosis is difficult only with clinical symptoms and it is recently confirmed with gene study. The genotype-phenotype correlations have been reported. We report a newborn with KRAS gene mutation. This is the second report of case with KRAS gene mutation in Korea. So we hope this case will be a help to diagnosis and treatment of Noonan syndrome from birth.
Genetic Association Studies
;
Heart Diseases
;
Humans
;
Infant, Newborn
;
Korea
;
Noonan Syndrome
;
Parturition
10.Warfarin-associated Fetal Intracranial Hemorrhage: A Case Report.
Ho Chang LEE ; Soo Youn CHO ; Hyun Joo LEE ; Chong Jai KIM ; Joong Shin PARK ; Je G CHI
Journal of Korean Medical Science 2003;18(5):764-767
A 27-yr-old woman who had been taking warfarin for 10 yr after mitral valve replacement became pregnant. After knowing her pregnancy, she received heparinization for nine weeks instead of warfarin, and took oral anticoagulant again. At 24 weeks of gestation, fetal ultrasound and MRI showed a left subdural hematoma, and the pregnancy was terminated. Subdural hematoma was demonstrated on autopsy. Fatal bleeding of the fetus is a rare complication of maternal warfarin medication, occurring mostly in the second or third trimester. There is no alternative regimen available, so that regular monitoring by fetal ultrasound and strict control of warfarin dose with regular measurement of prothrombin time are the best way to prevent intrauterine fetal death due to bleeding.
Adult
;
Anticoagulants/*adverse effects
;
Ductus Arteriosus, Patent/surgery
;
Female
;
Fetal Diseases/*chemically induced
;
Heart Valve Diseases/therapy
;
Hematoma/chemically induced
;
Heparin/adverse effects
;
Human
;
Intracranial Hemorrhages/*chemically induced
;
Maternal Exposure
;
Pregnancy
;
Pregnancy Complications, Hematologic
;
Prothrombin Time
;
Warfarin/*adverse effects

Result Analysis
Print
Save
E-mail